As a Free StocksGuide user, you can view scores for all 6,951 stocks worldwide.
8 Analysts have issued a Indivior forecast:
8 Analysts have issued a Indivior forecast:
Mar '25 |
+/-
%
|
||
Revenue | 1,500 1,500 |
83%
83%
|
|
Gross Profit | 1,260 1,260 |
86%
86%
|
|
EBITDA | 406 406 |
94%
94%
|
EBIT (Operating Income) EBIT | 388 388 |
107%
107%
|
Net Profit | -40 -40 |
1,200%
1,200%
|
In millions GBP.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in Slough, the United Kingdom.
Head office | United Kingdom |
CEO | Joseph Ciaffoni |
Employees | 1,041 |
Founded | 2014 |
Website | www.indivior.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.